Clinical Trial Update: Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating olfactory function in Parkinson's disease patients treated with rasagiline; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Parkinson´s Disease | Phase 4 | Status: COMPLETED